Page last updated: 2024-11-06

rufigallol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Rufigallol is a red-brown organic compound with the formula C14H4O8. It is a derivative of hexahydroxybenzophenone. Rufigallol can be synthesized by heating gallic acid with sulfuric acid. It has been investigated for its antioxidant and anticancer activities. Rufigallol exhibits strong scavenging activity against reactive oxygen species (ROS) and has shown potential in inhibiting the growth of cancer cells. It is also a useful reagent in organic synthesis and has applications in dye chemistry.'

rufigallol: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID65737
CHEMBL ID58972
CHEBI ID37500
SCHEMBL ID1230309
MeSH IDM0270084

Synonyms (21)

Synonym
1,2,3,5,6,7-hexahydroxyanthracene-9,10-dione
CHEBI:37500 ,
rufigallol
1,2,3,5,6,7-hexahydroxy-9,10-anthraquinone
rufigallic acid
1,2,3,5,6,7-hexahydroxy-9,10-anthracenedione
82-12-2
AKOS000277486
1,2,3,5,6,7-hexahydroxy-anthraquinone
CHEMBL58972
s977046n6i ,
unii-s977046n6i
ai3-00865
9,10-anthracenedione, 1,2,3,5,6,7-hexahydroxy-
rufigallol [mi]
1,2,3,5,6,7-hexahydroxyanthraquinone
c.i. 58600
SCHEMBL1230309
DTXSID1075359
rufigallussaure
Q3531502
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
hexahydroxyanthraquinone
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1858902Antimalarial activity against drug resistant Plasmodium falciparum D6 by 96-well microtitre plate method based scintillation counting analysis2021European journal of medicinal chemistry, Jan-15, Volume: 210Antimalarial application of quinones: A recent update.
AID1858850Antimalarial activity against wildtype Plasmodium falciparum D6 by 96-well microtitre plate method based scintillation counting analysis2021European journal of medicinal chemistry, Jan-15, Volume: 210Antimalarial application of quinones: A recent update.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.19

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.19 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.69 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.19)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]